Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II G Samsa, D Edelman, ML Rothman, GR Williams, J Lipscomb, D Matchar Pharmacoeconomics 15, 141-155, 1999 | 999 | 1999 |
Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology E Basch, AP Abernethy, CD Mullins, BB Reeve, ML Smith, SJ Coons, ... Journal of clinical oncology 30 (34), 4249-4255, 2012 | 528 | 2012 |
The burden of illness of cancer: economic cost and quality of life ML Brown, J Lipscomb, C Snyder Annual review of public health 22 (1), 91-113, 2001 | 445 | 2001 |
Time preference J Lipscomb Cost-effectiveness in health and medicine, 214-246, 1996 | 388 | 1996 |
Patient‐reported outcomes in cancer: a review of recent research and policy initiatives J Lipscomb, CC Gotay, CF Snyder CA: a cancer journal for clinicians 57 (5), 278-300, 2007 | 377 | 2007 |
Patient-reported outcomes: conceptual issues ML Rothman, P Beltran, JC Cappelleri, J Lipscomb, B Teschendorf, ... Value in Health 10, S66-S75, 2007 | 294 | 2007 |
Understanding cancer treatment and outcomes: the cancer care outcomes research and surveillance consortium JZ Ayanian, EA Chrischilles, RH Fletcher, MN Fouad, DP Harrington, ... Journal of clinical oncology: official journal of the American Society of …, 2004 | 292 | 2004 |
Epidemiology of recurrent cerebral infarction: a Medicare claims–based comparison of first and recurrent strokes on 2-year survival and cost GP Samsa, J Bian, J Lipscomb, DB Matchar Stroke 30 (2), 338-349, 1999 | 272 | 1999 |
Survival after sublobar resection versus lobectomy for clinical stage IA lung cancer: an analysis from the National Cancer Data Base OV Khullar, Y Liu, T Gillespie, KA Higgins, S Ramalingam, J Lipscomb, ... Journal of Thoracic Oncology 10 (11), 1625-1633, 2015 | 245 | 2015 |
Inpatient costs of specific cerebrovascular events at five academic medical centers. RG Holloway, DM Witter Jr, KB Lawton, J Lipscomb, G Samsa Neurology 46 (3), 854-860, 1996 | 211 | 1996 |
Productivity costs, time costs and health‐related quality of life: a response to the Erasmus Group MC Weinstein, JE Siegel, AM Garber, J Lipscomb, BR Luce, ... Health economics 6 (5), 505-510, 1997 | 190 | 1997 |
Racial differences in the presentation and outcomes of diffuse large B‐cell lymphoma in the United States PJ Shenoy, N Malik, A Nooka, R Sinha, KC Ward, OW Brawley, ... Cancer 117 (11), 2530-2540, 2011 | 189 | 2011 |
Outcomes assessment in cancer: measures, methods and applications J Lipscomb, CC Gotay, C Snyder Cambridge University Press, 2011 | 187 | 2011 |
Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke GP Samsa, DB Matchar, L Goldstein, A Bonito, PW Duncan, J Lipscomb, ... American heart journal 136 (4), 703-713, 1998 | 184 | 1998 |
Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers XC Wu, MJ Lund, GG Kimmick, LC Richardson, SA Sabatino, VW Chen, ... Journal of Clinical Oncology 30 (2), 142-150, 2012 | 180 | 2012 |
Time preference for health in cost-effectiveness analysis J Lipscomb Medical Care 27 (3), S233-S253, 1989 | 177 | 1989 |
First-and second-line bevacizumab in addition to chemotherapy for metastatic colorectal cancer: a United States–based cost-effectiveness analysis DA Goldstein, Q Chen, T Ayer, DH Howard, J Lipscomb, BF El-Rayes, ... Journal of Clinical Oncology 33 (10), 1112-1118, 2015 | 171 | 2015 |
Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke GP Samsa, RA Reutter, G Parmigiani, M Ancukiewicz, P Abrahamse, ... Journal of clinical epidemiology 52 (3), 259-271, 1999 | 165 | 1999 |
Patient-reported outcomes assessment in cancer trials: taking stock, moving forward J Lipscomb, BB Reeve, SB Clauser, JS Abrams, D Watkins Bruner, ... Journal of Clinical Oncology 25 (32), 5133-5140, 2007 | 161 | 2007 |
US valuation of health outcomes measured using the PROMIS-29 BM Craig, BB Reeve, PM Brown, D Cella, RD Hays, J Lipscomb, ... Value in Health 17 (8), 846-853, 2014 | 160 | 2014 |